๐๏ธ Verified NIH Record โข Updated 2026-03-24
Community Partnership for Telehealth Solutions to Convey Information and Enhance Care (NCT06542835)
Community Partnership for Telehealth Solutions to Counter Misinformation and Achieve Equity
๐ข Recruiting Observational / Diagnostic ๐ง Behavioral & Psychological Program Sponsor: University of Arizona
๐ฉบ Plain-English Summary (8th-Grade Level)
Non-randomized, two-arm stepped-wedge trial of a multi-level colorectal cancer screening intervention.
Who can join: Review the eligibility criteria below.
Location: AltaMed Health Services Corporation โ Los Angeles, California
Age range: 45 Years to 64 Years
๐งช Interventions in This Study
- Video text message (BEHAVIORAL)
- In-clinic CRC screening promotion (BEHAVIORAL)
- Mailed FIT (BEHAVIORAL)
- Social needs navigation (BEHAVIORAL)
- Reminders (BEHAVIORAL)
๐ "Do I Qualify?" โ 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria โ
๐ All Participating Trial Locations (1 Sites)
- AltaMed Health Services Corporation โ Los Angeles, California
๐ Contact the Study Coordinator
Phone: (503) 914-7100
Email: gdcoronado@arizona.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
๐ฐ Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Colorectal Cancer
- Impact of Colorectal Cancer and Nutrition Education Program Among Minority Patients With Type 2 Diabetes โ Los Angeles, California
- A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors โ Duarte, California
- Dose Escalation and Expansion Study of TROP2 CAR Engineered IL-15- Transduced Cord Blood-derived NK Cells in Combination With Cetuximab in Patient With Colorectal Cancer (CRC) With Minimal Residual Disease (MRD) โ Houston, Texas
- Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combined With Combination Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver โ Basking Ridge, New Jersey
- The PRIME-CRC Trial to Promote CRC Screening in Rural Communities โ Bastrop, Louisiana
- Radiation Therapy and Fluorouracil With or Without Combination Chemotherapy Followed by Surgery in Treating Patients With Stage II or Stage III Rectal Cancer โ Concord, California
Explore by condition: All Colorectal Cancer clinical trials
๐ก How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.